Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Assets (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Assets for 4 consecutive years, with $53.4 million as the latest value for Q3 2025.

  • Quarterly Assets rose 16.52% to $53.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $53.4 million through Sep 2025, up 16.52% year-over-year, with the annual reading at $53.4 million for FY2025, 16.52% up from the prior year.
  • Assets hit $53.4 million in Q3 2025 for Jin Medical International, up from $45.8 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $53.4 million in Q3 2025 to a low of $20.9 million in Q3 2022.
  • Historically, Assets has averaged $38.3 million across 4 years, with a median of $39.4 million in 2023.
  • Biggest five-year swings in Assets: surged 57.14% in 2023 and later increased 16.52% in 2025.
  • Year by year, Assets stood at $20.9 million in 2022, then soared by 57.14% to $32.9 million in 2023, then soared by 39.2% to $45.8 million in 2024, then rose by 16.52% to $53.4 million in 2025.
  • Business Quant data shows Assets for ZJYL at $53.4 million in Q3 2025, $45.8 million in Q3 2024, and $32.9 million in Q3 2023.